1. A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate Cancer. (March 2019) Authors: Rice, Stephanie R.; Olexa, Gloribel; Hussain, Arif; Mannuel, Heather; Naslund, Michael J.; Amin, Pradip; Kwok, Young Journal: American journal of clinical oncology Issue: Volume 42:Number 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer. (31st May 2019) Authors: Heath, Elisabeth; Heilbrun, Lance; Mannuel, Heather; Liu, Glenn; Lara, Primo; Monk, J. Paul; Flaig, Thomas; Zurita, Amado; Mack, Philip; Vaishampayan, Ulka; Stella, Philip; Smith, Daryn; Bolton, Susan; Hussain, Arif; Al‐Janadi, Anas; Silbiger, Daniel; Usman, Muhammad; Ivy, S. Percy Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: 1149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗